References:

Yu-Wai-Man P. Traumatic optic neuropathy—Clinical features and management issues. Taiwan journal of ophthalmology. 2015;5(1):3-8.

Chen B, Zhang H, Zhai Q, Li H, Wang C, Wang Y. Traumatic optic neuropathy: a review of current studies. Neurosurgical Review. 2022;45(3):1895-913.

Samardzic K, Samardzic J, Janjetovic Z, Samardzic I, Sekelj S, Latic-Hodzic L. Traumatic optic neuropathy-to treat or to observe? Acta Informatica Medica. 2012;20(2):131.

Kumar M, Kowsalya A, Narayanamoorthy J, Kumarasamy D, Balakrishnan H, Chaudhary S. Erythropoietin as a treatment option for indirect traumatic optic neuropathy: A pilot study. Indian Journal of Ophthalmology. 2023;71(1):235-40.

Lai Y-F, Lin T-Y, Ho P-K, Chen Y-H, Huang Y-C, Lu D-W. Erythropoietin in optic neuropathies: current future strategies for optic nerve protection and repair. International Journal of Molecular Sciences. 2022;23(13):7143.

Oh H-J, Yeo D-G, Hwang S-C. Surgical treatment for traumatic optic neuropathy. Korean Journal of Neurotrauma. 2018;14(2):55.

Yu‐Wai‐Man P, Griffiths PG. Steroids for traumatic optic neuropathy. Cochrane Database of Systematic Reviews. 2013(6):CD006032.

Steinsapir KD. Treatment of traumatic optic neuropathy with high-dose corticosteroid. Journal of neuro-ophthalmology. 2006;26(1):65-7.

Saxena R, Singh D, Menon V. Controversies in neuro-ophthalmology: steroid therapy for traumatic optic neuropathy. Indian journal of ophthalmology. 2014;62(10):1028-30.

Barker TH, Stone JC, Sears K, Klugar M, Tufanaru C, Leonardi-Bee J, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for randomized controlled trials. JBI evidence synthesis. 2023;21(3):494-506.

Munn Z, Barker TH, Moola S, Tufanaru C, Stern C, McArthur A, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI evidence synthesis. 2020;18(10):2127-33.

Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. bmj. 2016;355:i4919

Barker TH, Habibi N, Aromataris E, Stone JC, Leonardi-Bee J, Sears K, et al. The revised JBI critical appraisal tool for the assessment of risk of bias for quasi-experimental studies. JBI Evidence Synthesis. 2024;22(3):378-88.

Gao Y, Li J, Ma H, Nie C, Lv X, Lin X, et al. Endoscopic trans‐ethmosphenoid optic canal decompression is an optimal choice to save vision for indirect traumatic optic neuropathy. Acta ophthalmologica. 2022;100(2):e491-e501.

Rajiniganth M, Gupta AK, Gupta A, Bapuraj JR. Traumatic optic neuropathy: visual outcome following combined therapy protocol. Archives of Otolaryngology–Head & Neck Surgery. 2003;129(11):1203-6.

Levin LA, Beck RW, Joseph MP, Seiff S, Kraker R, Group IONTS. The treatment of traumatic optic neuropathy: the International Optic Nerve Trauma Study. Ophthalmology. 1999;106(7):1268-77.

Cook MW, Levin LA, Joseph MP, Pinczower EF. Traumatic optic neuropathy: a meta-analysis. Archives of Otolaryngology–Head & Neck Surgery. 1996;122(4):389-92.

Mauriello JA, DeLuca J, Krieger A, Schulder M, Frohman L. Management of traumatic optic neuropathy--a study of 23 patients. Br J Ophthalmol. 1992;76(6):349-52.

Chou PI, Sadun AA, Chen YC, Su WY, Lin SZ, Lee CC. Clinical experiences in the management of traumatic optic neuropathy. Neuro-Ophthalmology. 1996;16(6):325-36.

Mariak Z, Obuchowska I, Mariak Z, Stankiewicz A, Ustymowicz A, Proniewska-Skrȩtek E. High-dose steroid therapy of traumatic optic neuropathy may fail to protect the optic nerve permanently. Neuro-Ophthalmology. 1999;21(4):255-60.

Mine S, Yamakami I, Yamaura A, Hanawa K, Ikejiri M, Mizota A, et al. Outcome of traumatic optic neuropathy. Comparison between surgical and nonsurgical treatment. Acta Neurochirurgica. 1999;141(1):27-30.

Kountakis SE, Maillard AA, El-Harazi SM, Longhini L, Urso RG. Endoscopic optic nerve decompression for traumatic blindness. Otolaryngol Head Neck Surg. 2000;123(1 Pt 1):34-7.

Kitthaweesin K, Yospaiboon Y. Dexamethasone and methylprednisolone in treatment of indirect traumatic optic neuropathy. J Med Assoc Thai. 2001;84(5):628-34.

Yip CC, Chng NW, Au Eong KG, Heng WJ, Lim TH, Lim WK. Low-dose intravenous methylprednisolone or conservative treatment in the management of traumatic optic neuropathy. Eur J Ophthalmol. 2002;12(4):309-14.

Hsieh CH, Kuo YR, Hung HC, Tsai HH, Jeng SF. Indirect traumatic optic neuropathy complicated with periorbital facial bone fracture. J Trauma. 2004;56(4):795-801.

Lee KF, Muhd Nor NI, Yaakub A, Wan Hitam WH. Traumatic optic neuropathy: a review of 24 patients. Int J Ophthalmol. 2010;3(2):175-8.

Emanuelli E, Bignami M, Digilio E, Fusetti S, Volo T, Castelnuovo P. Post-traumatic optic neuropathy: our surgical and medical protocol. Eur Arch Otorhinolaryngol. 2015;272(11):3301-9.

Sosin M, De La Cruz C, Mundinger GS, Saadat SY, Nam AJ, Manson PN, et al. Treatment Outcomes following Traumatic Optic Neuropathy. Plast Reconstr Surg. 2016;137(1):231-8.

Pokharel S, Sherpa D, Shrestha R, Shakya K, Shrestha R, Malla OK, et al. Visual Outcome after Treatment with High Dose Intravenous Methylprednisolone in Indirect Traumatic Optic Neuropathy. J Nepal Health Res Counc. 2016;14(32):1-6.

Sefi-Yurdakul N, Koç F. Risk factors affecting the visual outcome in patients with indirect traumatic optic neuropathy. Int Ophthalmol. 2018;38(4):1647-52.

Kashkouli MB, Yousefi S, Nojomi M, Sanjari MS, Pakdel F, Entezari M, et al. Traumatic optic neuropathy treatment trial (TONTT): open label, phase 3, multicenter, semi-experimental trial. Graefes Arch Clin Exp Ophthalmol. 2018;256(1):209-18.

Chen HH, Lee MC, Tsai CH, Pan CH, Lin YT, Chen CT. Surgical Decompression or Corticosteroid Treatment of Indirect Traumatic Optic Neuropathy: A Randomized Controlled Trial. Annals of plastic surgery. 2020;84(1S Suppl 1):S80-S3.

Yu B, Ma YJ, Tu YH, Wu WC. Newly onset indirect traumatic optic neuropathy-surgical treatment first versus steroid treatment first. International Journal of Ophthalmology. 2020;13(1):124-8.

John A, Kakkanatt ACV, Mathai MT, Palatty BU, Kurian N, Sasidharan A. Traumatic optic neuropathy: Early detection and intervention in a tertiary care centre. Journal of Clinical and Diagnostic Research. 2020;14(4):NC05-NC8.

Gao Y, Li J, Ma H, Nie C, Lv X, Lin X, et al. Endoscopic trans-ethmosphenoid optic canal decompression is an optimal choice to save vision for indirect traumatic optic neuropathy. Acta Ophthalmol. 2022;100(2):e491-e501.

Wei W, Zhao SF, Li Y, Zhang JL, Wu JP, Liu HC, et al. The outcome of surgical and non-surgical treatments for traumatic optic neuropathy: a comparative study of 685 cases. Ann Transl Med. 2022;10(10):542.

Yang WG, Chen CT, Tsay PK, de Villa GH, Tsai YJ, Chen YR. Outcome for traumatic optic neuropathy--surgical versus nonsurgical treatment. Ann Plast Surg. 2004;52(1):36-42.

Challa NK, Aldakhil S. Clinical Spectrum of Indirect Traumatic Optic Neuropathy in South Indian Subjects Observational Study. Open Ophthalmology Journal. 2023;17(1): e187436412301040.